Although antipsychotic medications help manage clinical symptom severity, most people with schizophrenia continue to function poorly in the community.status: publishe
Introduction: The aim of this study was to objectively assess time spent in physical activity (PA) a...
Psychotic disorders such as schizophrenia affect 2–4% of the population and are one of the world’s l...
OBJECTIVE: This cross-sectional study considered whether variability in respiratory functioning coul...
Although antipsychotic medications help manage clinical symptom severity, most people with schizophr...
The primary aim was to determine whether the presence of metabolic syndrome (MetS) limits aerobic fi...
The purpose of this cross-sectional study was to investigate whether aerobic fitness contributes to ...
The purpose of this cross-sectional study was to investigate whether aerobic fitness contributes to ...
To examine walking capacity in patients with schizophrenia and the relation with quality of life and...
Background: In addition to the hallmark cognitive and functional impairments mounting evidence indic...
Background: In addition to the hallmark cognitive and functional impairments mounting evidence indic...
Low physical fitness has been recognised as a prominent behavioural risk factor for cardiovascular d...
BACKGROUND: Patients with schizophrenia report muscle weakness. The relation of this muscle weakness...
Introduction: Antipsychotic treatment can improve the symptoms of schizophrenia; however, residual s...
AIM: The primary aim of this study was to determine whether the presence of the metabolic syndrome (...
Cardiorespiratory fitness (CRF) is a major modifiable risk factor for cardiovascular disease (CVD). ...
Introduction: The aim of this study was to objectively assess time spent in physical activity (PA) a...
Psychotic disorders such as schizophrenia affect 2–4% of the population and are one of the world’s l...
OBJECTIVE: This cross-sectional study considered whether variability in respiratory functioning coul...
Although antipsychotic medications help manage clinical symptom severity, most people with schizophr...
The primary aim was to determine whether the presence of metabolic syndrome (MetS) limits aerobic fi...
The purpose of this cross-sectional study was to investigate whether aerobic fitness contributes to ...
The purpose of this cross-sectional study was to investigate whether aerobic fitness contributes to ...
To examine walking capacity in patients with schizophrenia and the relation with quality of life and...
Background: In addition to the hallmark cognitive and functional impairments mounting evidence indic...
Background: In addition to the hallmark cognitive and functional impairments mounting evidence indic...
Low physical fitness has been recognised as a prominent behavioural risk factor for cardiovascular d...
BACKGROUND: Patients with schizophrenia report muscle weakness. The relation of this muscle weakness...
Introduction: Antipsychotic treatment can improve the symptoms of schizophrenia; however, residual s...
AIM: The primary aim of this study was to determine whether the presence of the metabolic syndrome (...
Cardiorespiratory fitness (CRF) is a major modifiable risk factor for cardiovascular disease (CVD). ...
Introduction: The aim of this study was to objectively assess time spent in physical activity (PA) a...
Psychotic disorders such as schizophrenia affect 2–4% of the population and are one of the world’s l...
OBJECTIVE: This cross-sectional study considered whether variability in respiratory functioning coul...
DOI
Add to ORKG